MXPA02007271A - Compuestos de tipo pirrol, composiciones que los contienen, y metodos para el tratamiento de cancer o enfermedades virales. - Google Patents

Compuestos de tipo pirrol, composiciones que los contienen, y metodos para el tratamiento de cancer o enfermedades virales.

Info

Publication number
MXPA02007271A
MXPA02007271A MXPA02007271A MXPA02007271A MXPA02007271A MX PA02007271 A MXPA02007271 A MX PA02007271A MX PA02007271 A MXPA02007271 A MX PA02007271A MX PA02007271 A MXPA02007271 A MX PA02007271A MX PA02007271 A MXPA02007271 A MX PA02007271A
Authority
MX
Mexico
Prior art keywords
compositions
methods
type compounds
pyrrole type
treating cancer
Prior art date
Application number
MXPA02007271A
Other languages
English (en)
Inventor
Roy A Johnson
Original Assignee
Gemin X Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gemin X Biotechnologies Inc filed Critical Gemin X Biotechnologies Inc
Publication of MXPA02007271A publication Critical patent/MXPA02007271A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a compuestos de tipo pirrol novedosos, a composiciones que contienen compuestos de tipo pirrol y a metodos utiles para el tratamiento o la prevencion de cancer o de un trastorno neoplasico, que comprenden la administracion de una composicion que contiene un compuesto de tipo pirrol. Los compuestos, composiciones, y metodos de la presente invencion son tambien utiles para inhibir el crecimiento de una celula cancerosa o de una celula neoplasica. La presente invencion se refiere tambien a compuestos de tipo pirrol novedosos, a composiciones que los contienen, y a metodos utiles para el tratamiento o la prevencion de una infeccion viral. Los compuestos, composiciones, y metodos de la presente invencion son tambien utiles para inhibir la replicacion y/o infectividad de un virus.
MXPA02007271A 2000-01-26 2001-01-24 Compuestos de tipo pirrol, composiciones que los contienen, y metodos para el tratamiento de cancer o enfermedades virales. MXPA02007271A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/491,712 US6407244B1 (en) 2000-01-26 2000-01-26 Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
PCT/CA2001/000085 WO2001055131A2 (en) 2000-01-26 2001-01-24 Prodigiosin-derivatives as neoplastic and anti-viral agents

Publications (1)

Publication Number Publication Date
MXPA02007271A true MXPA02007271A (es) 2004-07-30

Family

ID=23953337

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02007271A MXPA02007271A (es) 2000-01-26 2001-01-24 Compuestos de tipo pirrol, composiciones que los contienen, y metodos para el tratamiento de cancer o enfermedades virales.

Country Status (19)

Country Link
US (2) US6407244B1 (es)
EP (2) EP1255753B1 (es)
JP (1) JP2003523352A (es)
KR (1) KR20020072295A (es)
CN (1) CN1419553A (es)
AT (1) ATE269859T1 (es)
AU (1) AU780647B2 (es)
BR (1) BR0107912A (es)
CA (1) CA2398173A1 (es)
CZ (1) CZ20022604A3 (es)
DE (1) DE60103978D1 (es)
IL (1) IL150817A0 (es)
MX (1) MXPA02007271A (es)
NO (1) NO20023486L (es)
NZ (1) NZ520361A (es)
PL (1) PL356932A1 (es)
SK (1) SK10952002A3 (es)
WO (1) WO2001055131A2 (es)
ZA (1) ZA200205838B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040014987A1 (en) * 2000-01-26 2004-01-22 Gemin X Biotechnologies Inc. Pyrrole-Type compounds, compositions, and methods for treating cancer or viral diseases
US6407244B1 (en) 2000-01-26 2002-06-18 Gemin X Biotechnologies Inc. Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
US7144912B2 (en) * 2001-07-18 2006-12-05 Gemin X Biotechnologies Inc. Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
US20030119894A1 (en) * 2001-07-20 2003-06-26 Gemin X Biotechnologies Inc. Methods for treatment of cancer or neoplastic disease and for inhibiting growth of cancer cells and neoplastic cells
WO2004002367A1 (fr) * 2002-06-27 2004-01-08 Microport Medical (Shanghai) Co., Ltd. Stent eluant des medicaments
SI1644363T1 (sl) 2003-05-30 2012-07-31 Gemin X Pharmaceuticals Canada Inc Triheterociklične spojine sestavki in postopki za zdravljenje raka
JP5224818B2 (ja) * 2004-12-28 2013-07-03 ジェミン エックス ファーマシューティカルズ カナダ インコーポレイテッド ジピロール化合物およびそれを含む医薬組成物
EP2170062A4 (en) * 2007-07-12 2010-12-29 Tragara Pharmaceuticals Inc METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER DISORDERS, TUMORS AND TUMOR-DISORDED DISEASES
CA2707424A1 (en) * 2007-11-28 2009-06-04 Tragara Pharmaceuticals, Inc. Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders
CN103145719B (zh) * 2013-02-27 2015-04-29 中国科学院化学研究所 灵菌红素衍生物的制备方法
US10322123B2 (en) 2014-09-29 2019-06-18 The Penn State Research Foundation Compound for anti-cancer therapy that acts by targeting GOF mutant P53 and stimulates P73 to restore the P53 pathway signaling
US10111554B2 (en) 2015-03-20 2018-10-30 Meltz, LLC Systems for and methods of controlled liquid food or beverage product creation
US10314320B2 (en) 2015-03-20 2019-06-11 Meltz, LLC Systems for controlled liquid food or beverage product creation
KR101785428B1 (ko) 2016-04-21 2017-10-16 (주) 마이크로프랜드 반도체소자 테스트소켓
WO2018200922A1 (en) 2017-04-27 2018-11-01 Meltz, LLC Method for centrifugal extraction and apparatus suitable for carrying out this method
CN109942559A (zh) * 2019-03-08 2019-06-28 上海大学 呋喃二联吡咯化合物及其制备方法
US11724849B2 (en) 2019-06-07 2023-08-15 Cometeer, Inc. Packaging and method for single serve beverage product

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4266028A (en) * 1979-02-21 1981-05-05 Kirin Beer Kabushiki Kaisha Process for preparation of prodigiosin
JPS55162768A (en) * 1979-06-06 1980-12-18 Kirin Brewery Co Ltd Carcinostatic
JPS6134403A (ja) 1984-07-26 1986-02-18 Nec Corp 光干渉計
JPS61280429A (ja) 1985-06-06 1986-12-11 Chugai Pharmaceut Co Ltd 免疫抑制剤
JPH02250828A (ja) 1989-03-23 1990-10-08 Nippon Kayaku Co Ltd 新規免疫抑制剤
JPH0586374A (ja) 1991-09-26 1993-04-06 Teikoku Sekiyu Kk 炭水化物を可燃性のガスに分解する方法
GB9326284D0 (en) 1993-12-23 1994-02-23 Erba Carlo Spa Pyrrolydenemethyl-derivatives and process for their preparation
JPH0930967A (ja) 1995-07-17 1997-02-04 Chugai Pharmaceut Co Ltd 抗潰瘍剤
GB9603212D0 (en) 1996-02-15 1996-04-17 Pharmacia Spa Process for the preparation of 2,2'-bipyrrolyl-pyrromethane derivatives
GB9619706D0 (en) 1996-09-20 1996-11-06 Pharmacia Spa Synergistic immunosuppressant composition containing a 2,2'-bi-1H-pyrrole comp und
JP3949196B2 (ja) 1996-10-23 2007-07-25 赤穂化成株式会社 免疫抑制剤
JP3949198B2 (ja) 1996-10-23 2007-07-25 赤穂化成株式会社 V−ATPase 脱共役 H+ ポンプ阻害剤
GB9705035D0 (en) 1997-03-11 1997-04-30 Pharmacia & Upjohn Spa Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
KR100252197B1 (ko) 1997-09-20 2000-04-15 박호군 세라시아 마르세센스 균주의 배양액으로 부터 분리한 면역억제제용 프로디지오신
JPH11209283A (ja) 1997-10-01 1999-08-03 Ako Kasei Co Ltd 抗癌剤
GB9726130D0 (en) 1997-12-10 1998-02-11 Pharmacia & Upjohn Spa 2,2'-BI-1H-pyrrole derivatives useful in the treatment of leukemia brought on by HTLV-I
GB9802745D0 (en) 1998-02-09 1998-04-08 Pharmacia & Upjohn Spa Benzyloxy prodigiosine compounds
US6407244B1 (en) 2000-01-26 2002-06-18 Gemin X Biotechnologies Inc. Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases

Also Published As

Publication number Publication date
DE60103978D1 (de) 2004-07-29
EP1255753A2 (en) 2002-11-13
BR0107912A (pt) 2002-12-10
SK10952002A3 (sk) 2003-01-09
NO20023486D0 (no) 2002-07-22
NO20023486L (no) 2002-09-04
CN1419553A (zh) 2003-05-21
CZ20022604A3 (cs) 2003-01-15
EP1431286A3 (en) 2004-07-28
PL356932A1 (en) 2004-07-12
US20030009032A1 (en) 2003-01-09
US6602879B2 (en) 2003-08-05
US6407244B1 (en) 2002-06-18
CA2398173A1 (en) 2001-08-02
KR20020072295A (ko) 2002-09-14
JP2003523352A (ja) 2003-08-05
ZA200205838B (en) 2004-03-08
EP1255753B1 (en) 2004-06-23
EP1431286A2 (en) 2004-06-23
NZ520361A (en) 2004-02-27
ATE269859T1 (de) 2004-07-15
WO2001055131A2 (en) 2001-08-02
AU2991201A (en) 2001-08-07
IL150817A0 (en) 2003-02-12
WO2001055131A3 (en) 2002-03-07
AU780647B2 (en) 2005-04-07

Similar Documents

Publication Publication Date Title
IL172189A0 (en) Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
MXPA02007271A (es) Compuestos de tipo pirrol, composiciones que los contienen, y metodos para el tratamiento de cancer o enfermedades virales.
WO2005117908A3 (en) Triheterocyclic compounds compositions, and methods for treating cancer or viral diseases
AP1782A (en) Use of compounds ?-D or ?-L nucleoside for treating hepatitis C virus.
NZ515392A (en) Respiratory syncytial virus replication inhibitors
PT1404347E (pt) Nucleosidos 4'-substituidos para o tratamento de doencas mediadas pelo virus da hepatite c
EP1455809A4 (en) INHIBITORS OF HEPATITIS C VIRUSES
ATE238981T1 (de) Antitumorwirkstoffe
WO2002032942A3 (en) Compositions and methods for modulating rsv infection and immunity
DK0714387T3 (da) Hidtil ukendte bis-naphthalimider til behandling af cancer
WO2003053332A3 (en) Composition and method for treating viral infection
MXPA03005374A (es) Carbazoles antitumorales.
MXPA04000402A (es) Compuestos de tipo pirrol, composiciones que los contienen, y metodos que los emplean para el tratamiento de cancer y enfermedades virales y para causar inmunosupresion.
WO2001014576A3 (en) Process and intermediates for the preparation of isoxazolecaroxamides and analogues
ATE493408T1 (de) Antiinfektiöse mittel
WO2003017943A3 (en) Therapeutic compositions and methods for treating viral infection
WO2003015714A3 (en) Compositions and therapeutic methods for viral infection
AU4485101A (en) Antiviral therapy
UA101465C2 (ru) Использование индольного соединения для лечения или предупреждения инфицирования вирусом гепатита с

Legal Events

Date Code Title Description
FG Grant or registration